• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BRCA1 缺失诱导前列腺癌细胞中 GADD153 介导的多柔比星耐药性。

BRCA1 loss induces GADD153-mediated doxorubicin resistance in prostate cancer.

机构信息

Laboratory of Cancer and Apoptosis, Department of Biological Chemistry, School of Scences, University of Buenos Aires, CONICET, Buenos Aires, Argentina.

出版信息

Mol Cancer Res. 2011 Aug;9(8):1078-90. doi: 10.1158/1541-7786.MCR-11-0155. Epub 2011 Jun 23.

DOI:10.1158/1541-7786.MCR-11-0155
PMID:21700680
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6959536/
Abstract

BRCA1 plays numerous roles in the regulation of genome integrity and chemoresistance. Although BRCA1 interaction with key proteins involved in DNA repair is well known, its role as a coregulator in the transcriptional response to DNA damage remains poorly understood. In this study, we show that BRCA1 plays a central role in the transcriptional response to genotoxic stress in prostate cancer. BRCA1 expression mediates apoptosis, cell-cycle arrest, and decreased viability in response to doxorubicin treatment. Xenograft studies using human prostate carcinoma PC3 cells show that BRCA1 depletion results in increased tumor growth. A focused survey of BRCA1-regulated genes in prostate carcinoma reveals that multiple regulators of genome stability and cell-cycle control, including BLM, FEN1, DDB2, H3F3B, BRCA2, CCNB2, MAD2L1, and GADD153, are direct transcriptional targets of BRCA1. Furthermore, we show that BRCA1 targets GADD153 promoter to increase its transcription in response to DNA damage. Finally, GADD153 depletion significantly abrogates BRCA1 influence on cell-cycle progression and cell death in response to doxorubicin treatment. These findings define a novel transcriptional pathway through which BRCA1 orchestrates cell fate decisions in response to genotoxic insults, and suggest that BRCA1 status should be considered for new chemotherapeutic treatment strategies in prostate cancer.

摘要

BRCA1 在基因组完整性和化学抗性的调节中发挥多种作用。虽然 BRCA1 与参与 DNA 修复的关键蛋白的相互作用是众所周知的,但它作为 DNA 损伤转录反应的核心调节剂的作用仍知之甚少。在这项研究中,我们表明 BRCA1 在前列腺癌对遗传毒性应激的转录反应中发挥核心作用。BRCA1 的表达介导了多柔比星治疗时的细胞凋亡、细胞周期停滞和活力下降。使用人前列腺癌细胞 PC3 的异种移植研究表明,BRCA1 的耗竭导致肿瘤生长增加。对前列腺癌中 BRCA1 调节基因的集中调查显示,基因组稳定性和细胞周期控制的多个调节剂,包括 BLM、FEN1、DDB2、H3F3B、BRCA2、CCNB2、MAD2L1 和 GADD153,是 BRCA1 的直接转录靶标。此外,我们表明 BRCA1 靶向 GADD153 启动子以增加其在 DNA 损伤后的转录。最后,GADD153 的耗竭显著削弱了 BRCA1 对多柔比星治疗时细胞周期进程和细胞死亡的影响。这些发现定义了一个新的转录途径,通过该途径,BRCA1 协调细胞命运决策以应对遗传毒性损伤,并表明在前列腺癌的新化疗治疗策略中应考虑 BRCA1 状态。

相似文献

1
BRCA1 loss induces GADD153-mediated doxorubicin resistance in prostate cancer.BRCA1 缺失诱导前列腺癌细胞中 GADD153 介导的多柔比星耐药性。
Mol Cancer Res. 2011 Aug;9(8):1078-90. doi: 10.1158/1541-7786.MCR-11-0155. Epub 2011 Jun 23.
2
BRCA1 and p53 regulate critical prostate cancer pathways.BRCA1 和 p53 调控关键的前列腺癌通路。
Prostate Cancer Prostatic Dis. 2013 Sep;16(3):233-8. doi: 10.1038/pcan.2013.12. Epub 2013 May 14.
3
Dynamic coregulatory complex containing BRCA1, E2F1 and CtIP controls ATM transcription.包含BRCA1、E2F1和CtIP的动态共调节复合物控制ATM转录。
Cell Physiol Biochem. 2012;30(3):596-608. doi: 10.1159/000341441. Epub 2012 Jul 27.
4
Association of HO-1 and BRCA1 Is Critical for the Maintenance of Cellular Homeostasis in Prostate Cancer.HO-1 和 BRCA1 的关联对前列腺癌细胞内稳态的维持至关重要。
Mol Cancer Res. 2015 Nov;13(11):1455-64. doi: 10.1158/1541-7786.MCR-15-0150-T. Epub 2015 Jul 30.
5
Induction of apoptosis coupled to endoplasmic reticulum stress in human prostate cancer cells by n-butylidenephthalide.正丁烯基苯酞诱导人前列腺癌细胞凋亡及其与内质网应激的关系
PLoS One. 2012;7(3):e33742. doi: 10.1371/journal.pone.0033742. Epub 2012 Mar 28.
6
Down-regulation of BRCA1 and BRCA2 in human ovarian cancer cells exposed to adriamycin and ultraviolet radiation.阿霉素和紫外线照射下人卵巢癌细胞中BRCA1和BRCA2的下调。
Int J Cancer. 1998 Aug 12;77(4):600-9. doi: 10.1002/(sici)1097-0215(19980812)77:4<600::aid-ijc21>3.0.co;2-8.
7
BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targets.BRCA1 引导一种选择性的、依赖 p53 的转录反应,作用于生长停滞和 DNA 修复靶点。
Mol Cell Biol. 2002 Jun;22(12):4280-92. doi: 10.1128/MCB.22.12.4280-4292.2002.
8
BRCA1 as a potential human prostate tumor suppressor: modulation of proliferation, damage responses and expression of cell regulatory proteins.BRCA1作为一种潜在的人类前列腺肿瘤抑制因子:对细胞增殖、损伤反应及细胞调节蛋白表达的调控
Oncogene. 1998 Jun 11;16(23):3069-82. doi: 10.1038/sj.onc.1202116.
9
Endoplasmic reticulum stress-induced resistance to doxorubicin is reversed by paeonol treatment in human hepatocellular carcinoma cells.丹皮酚处理逆转内质网应激诱导的人肝癌细胞对阿霉素耐药。
PLoS One. 2013 May 3;8(5):e62627. doi: 10.1371/journal.pone.0062627. Print 2013.
10
[DNA damage induces BRCA1 distribution alteration in prostate cancer cell lines].[DNA损伤诱导前列腺癌细胞系中BRCA1分布改变]
Zhonghua Nan Ke Xue. 2008 Aug;14(8):685-9.

引用本文的文献

1
An overview of RecQ helicases and related diseases.RecQ解旋酶及其相关疾病概述。
Aging (Albany NY). 2025 Jul 25;17(7):1881-1907. doi: 10.18632/aging.206291.
2
Functions of BLM Helicase in Cells: Is It Acting Like a Double-Edged Sword?BLM解旋酶在细胞中的功能:它是否像一把双刃剑?
Front Genet. 2021 Mar 12;12:634789. doi: 10.3389/fgene.2021.634789. eCollection 2021.
3
Homologous repair deficiency score for identifying breast cancers with defective DNA damage response.同源重组修复缺陷评分用于鉴定具有 DNA 损伤反应缺陷的乳腺癌。
Sci Rep. 2020 Jul 27;10(1):12506. doi: 10.1038/s41598-020-68176-y.
4
CTBP1 depletion on prostate tumors deregulates miRNA/mRNA expression and impairs cancer progression in metabolic syndrome mice.CTBP1 缺失会使前列腺肿瘤中的 miRNA/mRNA 表达失调,并损害代谢综合征小鼠中的肿瘤进展。
Cell Death Dis. 2019 Apr 1;10(4):299. doi: 10.1038/s41419-019-1535-z.
5
CTBP1 and metabolic syndrome induce an mRNA and miRNA expression profile critical for breast cancer progression and metastasis.CTBP1与代谢综合征诱导出对乳腺癌进展和转移至关重要的mRNA和miRNA表达谱。
Oncotarget. 2018 Feb 13;9(17):13848-13858. doi: 10.18632/oncotarget.24486. eCollection 2018 Mar 2.
6
EWS-FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma.EWS-FLI1 增加转录以导致 Ewing 肉瘤中的 R 环并阻断 BRCA1 修复。
Nature. 2018 Mar 15;555(7696):387-391. doi: 10.1038/nature25748. Epub 2018 Mar 7.
7
Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers.BLM 的过表达促进三阴性乳腺癌和浆液性卵巢癌中的 DNA 损伤,并增加对铂盐的敏感性。
Ann Oncol. 2018 Apr 1;29(4):903-909. doi: 10.1093/annonc/mdy049.
8
Quercetin reverses the doxorubicin resistance of prostate cancer cells by downregulating the expression of c-met.槲皮素通过下调c-met的表达来逆转前列腺癌细胞对阿霉素的耐药性。
Oncol Lett. 2018 Feb;15(2):2252-2258. doi: 10.3892/ol.2017.7561. Epub 2017 Dec 8.
9
BRCA1-regulated RRM2 expression protects glioblastoma cells from endogenous replication stress and promotes tumorigenicity.BRCA1 调控的 RRM2 表达可保护神经胶质瘤细胞免受内源性复制应激,并促进肿瘤发生。
Nat Commun. 2016 Nov 15;7:13398. doi: 10.1038/ncomms13398.
10
Insights into a novel nuclear function for Fascin in the regulation of the amino-acid transporter SLC3A2.揭示 Fascin 在调节氨基酸转运蛋白 SLC3A2 中的新型核功能。
Sci Rep. 2016 Nov 7;6:36699. doi: 10.1038/srep36699.

本文引用的文献

1
Transcriptional regulation of BRCA1 expression by a metabolic switch.代谢开关对 BRCA1 表达的转录调控。
Nat Struct Mol Biol. 2010 Dec;17(12):1406-13. doi: 10.1038/nsmb.1941. Epub 2010 Nov 21.
2
Immunohistochemical expression of BRCA1 and lethal prostate cancer.BRCA1 的免疫组化表达与致命性前列腺癌。
Cancer Res. 2010 Apr 15;70(8):3136-9. doi: 10.1158/0008-5472.CAN-09-4100. Epub 2010 Apr 13.
3
Germline BRCA mutations denote a clinicopathologic subset of prostate cancer.胚系 BRCA 突变表示前列腺癌的一种临床病理亚组。
Clin Cancer Res. 2010 Apr 1;16(7):2115-21. doi: 10.1158/1078-0432.CCR-09-2871. Epub 2010 Mar 9.
4
Linking ER Stress to Autophagy: Potential Implications for Cancer Therapy.内质网应激与自噬的关联:对癌症治疗的潜在影响
Int J Cell Biol. 2010;2010:930509. doi: 10.1155/2010/930509. Epub 2010 Jan 17.
5
Sensitivity and acquired resistance of BRCA1;p53-deficient mouse mammary tumors to the topoisomerase I inhibitor topotecan.BRCA1;p53 缺陷型鼠乳腺肿瘤对拓扑异构酶 I 抑制剂拓扑替康的敏感性和获得性耐药。
Cancer Res. 2010 Feb 15;70(4):1700-10. doi: 10.1158/0008-5472.CAN-09-3367. Epub 2010 Feb 9.
6
Transcriptional autoregulation by BRCA1.BRCA1 的转录自调控。
Cancer Res. 2010 Jan 15;70(2):532-42. doi: 10.1158/0008-5472.CAN-09-1477. Epub 2010 Jan 12.
7
Targeted chemotherapy? Platinum in BRCA1-dysfunctional breast cancer.靶向化疗?BRCA1功能失调型乳腺癌中的铂类药物
J Clin Oncol. 2010 Jan 20;28(3):361-3. doi: 10.1200/JCO.2009.24.0838. Epub 2009 Dec 14.
8
Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells.内源性血红素加氧酶 1 在调节前列腺癌细胞侵袭潜能中的关键作用。
Mol Cancer Res. 2009 Nov;7(11):1745-55. doi: 10.1158/1541-7786.MCR-08-0325. Epub 2009 Nov 10.
9
Identification of new Rel/NFkappaB regulatory networks by focused genome location analysis.通过聚焦基因组定位分析鉴定新的Rel/NFκB调控网络。
Cell Cycle. 2009 Jul 1;8(13):2093-100. doi: 10.4161/cc.8.13.8926. Epub 2009 Jul 5.
10
Chemotherapeutic sensitization by endoplasmic reticulum stress: increasing the efficacy of taxane against prostate cancer.内质网应激介导的化疗增敏作用:提高紫杉烷对前列腺癌的疗效
Cancer Biol Ther. 2009 Jan;8(2):146-52. doi: 10.4161/cbt.8.2.7087. Epub 2009 Feb 1.